![Charlie Petty](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charlie Petty
Fundador en Adjuvant Capital LP .
Cargos activos de Charlie Petty
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Fundador | 01/10/2018 | - |
Inversor de Capital Privado | 01/10/2018 | - | |
Curevo, Inc.
![]() Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Director/Miembro de la Junta | 01/12/2021 | - |
VitriVax, Inc.
![]() VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | Director/Miembro de la Junta | 01/12/2020 | - |
Nucleate Bio, Inc. | Consultor / Asesor | 01/01/2021 | - |
Effective Giving | Consultor / Asesor | 01/02/2022 | - |
Global Health Investment Corp. | Director/Miembro de la Junta | 01/03/2022 | - |
Historial de carrera de Charlie Petty
Antiguos cargos conocidos de Charlie Petty.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Codagenix, Inc.
![]() Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | Director/Miembro de la Junta | 01/01/2020 | 01/04/2023 |
Formación de Charlie Petty.
Virginia Polytechnic Institute & State University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
India | 2 |
Países Bajos | 2 |
Operativa
Director/Board Member | 4 |
Consultant / Advisor | 2 |
Founder | 1 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Codagenix, Inc.
![]() Codagenix, Inc. Medical/Nursing ServicesHealth Services Codagenix, Inc. provides platform technology to construct viral vaccines against multiple targets. It focuses on SAVE platform technology that utilizes computer-based rational design of viral genomes for the design and construction of vaccines for a range of medically important human diseases. The company was founded by J. Robert Coleman, Eckard Wimmer, Charlie Petty and Steffen Mueller in 2009 and is headquartered in Farmingdale, NY. | Health Services |
Curevo, Inc.
![]() Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Health Technology |
VitriVax, Inc.
![]() VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | Health Technology |
Nucleate Bio, Inc. | |
Effective Giving | |
Global Health Investment Corp. |
- Bolsa de valores
- Insiders
- Charlie Petty
- Experiencia